In COX-mediated fatty acids, PGE2-EP3 signaling and PGD2 in bradykinin-mediated angioedema are only a negative regulator for angioedema, suggesting that COX inhibitors might influence pathogenesis mediated by this signaling. The gene discussed is KNG1; the disease is angioedema.